Article information
Full text is only aviable in PDF
References
[1]
JT Sherwood, M Brock.
Lung cancer: new surgical approaches.
Respirology, 12 (2007), pp. 326-332
[2]
PE van Schil.
Surgery for non small cell lung cancer.
Lung Cancer, 34 (2001), pp. 127-132
[3]
PC Hoffman, AM Mauer, EE Vokes.
Lung cancer.
Lancet, 355 (2000), pp. 479-485
[4]
A Pennathur, JD Luketich, S Burton, G Abbas, DE Heron, DE Fernando, et al.
Stereotactic radiosurgery for the treatment of lung neoplasm: initial experience.
Ann Thorac Surg, 83 (2007), pp. 1820-1825
[5]
RJ McKenna, W Houck, CB Fuller.
Video-assisted thoracic surgery lobectomy: experience with 1,100 cases.
Ann Thorac Surg, 81 (2006), pp. 421-426
[6]
JJ Rivas de Andrés.
Cirugía videotoracoscópica (CVT).
¿Proceso de transición hacia la cirugía robótica? Pneuma, 1 (2005), pp. 139-141
[7]
T de Baere, D Elias, C Dromain, MG Din, V Kouch, M Ducreux, et al.
Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year.
AJR Am J Roentgenol, 175 (2000), pp. 1619-1625
[8]
RA Lencioni, HP Allgaier, D Cioni, M Olschewski, P Delbert, L Crocceti, et al.
Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection.
Radiology, 228 (2003), pp. 235-240
[9]
MAC Ambrogi, G Fontanini, R Croni, P Faviana, O Fanucci, A Mussi.
Biologic effects of radiofrequency thermal ablation on non-small cell lung cancer: results of a pilot study.
J Thorac Cardiovasc Surg, 131 (2006), pp. 1002-1006
[10]
MB Lilly, IA Brezovich, W Atkinson, D Chakraborty, JR Durant, J Ingram, et al.
Hyperthermia with implanted electrodes: in vitro and in vivo correlations.
Int J Radiat Oncol Biol Phys, 9 (1983), pp. 372-382
[11]
DE Dupuy, RJ Zagoria, W Akerley, WW Mayo-Smith, P Kavanagh, H Safran.
Percutaneous radiofrequency ablation of malignancies in the lung.
AJR Am J Roentgenol, 174 (2000), pp. 57-59
[12]
LJ Herrera, HC Fernando, Y Perry, WE Gooding, PO Buenaventura, NA Christie, et al.
Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates.
J Thorac Cardiovasc Surg, 125 (2003), pp. 929-937
[13]
RD Suh, AB Wallace, RE Sheehan, S Heinze, J Goldin.
Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation – preliminary results.
Radiology, 229 (2003), pp. 821-829
[14]
K Steinke, J King, D Glenn, DL Morris.
Radiologic appearance and complications of percutaneous computed tomography-guided radiofrequency ablated pulmonary metastases from colorectal carcinoma.
J Comput Assist Tomogr, 27 (2003), pp. 750-757
[15]
K Yasui, S Kanazawa, Y Sano, T Fujiwara, S Kagawa, H Mimura, et al.
Thoracic tumors treated with CT guided radiofrequency ablation: initial experience.
Radiology, 231 (2004), pp. 850-857
[16]
G Belfiore, G Moggio, E Tedeschi, M Greco, R Cioffi, F Cincotti, et al.
CT-guided radiofrequency ablation: a potential complementary therapy for patients with unresectable primary lung cancer – a preliminary report of 33 patients.
AJR Am J Roentgenol, 183 (2004), pp. 1003-1011
[17]
S Kang, R Luo, W Liao, H Wu, X Zhang, Y Meng.
Single group study to evaluate the feasibility and complications of radiofrequency ablation and usefulness of post treatment position emission tomography in lung tumours.
World J Surg Oncol, 2 (2004), pp. 30-36
[18]
E van Sonnenberg, S Shankar, PR Morrison, RT Nair, SG Silverman, M Jakditsch, et al.
Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience? Technical and multidisciplinary considerations in 30 patients.
AJR Am J Roentgenol, 184 (2005), pp. 381-390
[19]
HC Fernando, A De Hoyos, RJ Landreneau, S Gilbert, W Gooding, PO Buenaventura, et al.
Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates.
J Thorac Cardiovasc Surg, 129 (2005), pp. 639-644
[20]
T de Baere, J Palussiere, A Auperin, A Hakime, M Abdel-Rehim, M Kind, et al.
Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation.
Radiology, 240 (2006), pp. 587-596
[21]
M Lee, G Jin, SN Goldberg, YC Lee, GH Chung, YM Han, et al.
Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report.
Radiology, 230 (2004), pp. 125-134
[22]
T Hiraki, J Sakurai, T Tsuda, H Gobara, Y Sano, T Mukai, et al.
Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: evaluation based on preliminary review of 342 tumors.
Cancer, 107 (2006), pp. 2873-2880
[23]
DE Dupuy, T diPetrillo, S Gandhi, N Ready, T Ng, W Donat, et al.
Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer.
Chest, 129 (2006), pp. 738-745
[24]
RJ Ginsberg, LV Rubinstein.
Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer.
Ann Thorac Surg, 60 (1995), pp. 615-623
[25]
American Joint Committee on Cancer.
AJCC cancer staging manual, 6th ed., pp. 167-181
[26]
SC Rose, PA Thistlethwaite, PE Sewell, RB Vance.
Lung cancer and radiofrequency ablation.
J Vasc Interv Radiol, 17 (2006), pp. 927-951
[27]
C Simon, TA Dupuy Dipetrillo, H Safran, CA Grieco, T Ng, WW Mayo-Smith.
Pulmonary radiofrequency ablation: long term safety and efficacy in 153 patients.
Radiology, 243 (2007), pp. 268-275
[28]
A el-Sherif, JD Luketich, RJ Landreneau, HC Fernando.
New therapeutic approaches for early stage non-small cell lung cancer.
Surg Oncol, 14 (2005), pp. 27-32
[29]
J Pfannschmidt, T Muley, H Hoffmann, H Dienemann.
Prognostic factor and survival after complete resection of pulmonary metastases from colorectal carcinoma: experience in 167 patients.
J Thorac Cardiovasc Surg, 126 (2003), pp. 732-739
[30]
H Kelly, RM Golberg.
Systemic therapy for metastatic colorectal cancer: current options, current evidence.
J Clin Oncol, 23 (2005), pp. 4553-4560
[31]
K Yamakado, S Hase, T Matsouka, N Tanigawa, A Nakatsuka, H Takaki, et al.
Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan.
J Vasc Interv Radiol, 18 (2007), pp. 393-398
[32]
AR Gillams.
Complications of percutaneous therapy.
Cancer Imaging, 5 (2005), pp. 110-113
[33]
R Suh, K Reckamp, M Zeidler, R Cameron.
Radiofrequency ablation in lung cancer: promising results in safety and efficacy.
Oncology (Williston Park), 11 (2005), pp. 12-21
[34]
J Tominaga, H Miyachi, K Takase, T Matsuhashi, T Yamada, A Sato, et al.
Time-related changes in computed tomographic appearance and pathologic findings after radiofrequency ablation of the rabbit lung: preliminary experimental study.
J Vasc Interv Radiol, 16 (2005), pp. 1719-1726
[35]
A Yamamoto, K Nakamura, T Matsuoka, M Toyoshima, T Okuma, Y Oyama, et al.
Radiofrequency ablation in a porcine lung model: correlation between CT and histopathologic findings.
AJR Am J Roentgenol, 185 (2005), pp. 1299-1306
[36]
Y Oyama, K Nakamura, T Matsuoka, M Toyoshima, A Yamamoto, T Okuma, et al.
Radiofrequency ablated lesion in the normal porcine lung: long-term follow-up with MRI and pathology.
Cardiovasc Intervent Radiol, 28 (2005), pp. 346-353
[37]
K Ahrar, R Price, MJ Wallace, DC Madoff, S Gupta, FA Morello, et al.
Percutaneous radiofrequency ablation of lung tumors in a large animal model.
J Vasc Interv Radiol, 14 (2003), pp. 1037-1043
[38]
CL Nguyen, WJ Scott, NA Young, T Rader, LR Giles, M Golberg.
Radiofrequency ablation of primary lung cancer: results from an ablate and resect pilot study.
Chest, 128 (2005), pp. 3507-3511
[39]
S Rossi, R Dore, A Cascina, V Vespro, F Garbagnati, L Rosa, et al.
Percutaneous computed tomography-guided radiofrequency thermal ablation of small unresectable lung tumours.
Eur Respir J, 27 (2006), pp. 556-563
[40]
JD Bojarski, DE Dupuy, WW Mayo-Smith.
CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors.
AJR Am J Roentgenol, 185 (2005), pp. 466-471
[41]
AR Gillams.
Image guided tumour ablation.
Cancer Imaging, 5 (2005), pp. 103-109
[42]
D Haemmerich, PF Laeseke.
Thermal tumour ablation: devices, clinical applications and future directions.
Int J Hyperthermia, 21 (2005), pp. 755-760
[43]
WK Lo, E van Sonnenberg, S Shankar, PR Morrison, SG Silverman, K Tuncali, et al.
Percutaneous CT-guided radiofrequency ablation of symptomatic bilateral adrenal metastases in a single session.
J Vasc Interv Radiol, 17 (2006), pp. 175-179
Copyright © 2008. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
